In a filing, Vir Biotechnology Inc revealed its Director SCANGOS GEORGE A unloaded Company’s shares for reported $0.21 million on Feb 26 ’24. In the deal valued at $11.65 per share,17,722 shares were sold. As a result of this transaction, SCANGOS GEORGE A now holds 112,989 shares worth roughly $1.13 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Pang Phillip sold 14,568 shares, generating $146,344 in total proceeds. Upon selling the shares at $10.05, the EVP & Chief Medical Officer now owns 250,111 shares.
Before that, HANLY ANN M. sold 12,296 shares. Vir Biotechnology Inc shares valued at $123,521 were divested by the EVP & Chief Technology Officer at a price of $10.05 per share. As a result of the transaction, HANLY ANN M. now holds 134,780 shares, worth roughly $1.34 million.
JP Morgan downgraded its Vir Biotechnology Inc [VIR] rating to a Neutral from a an Overweight in a research note published on January 29, 2024; the price target was decreased to $9 from $23. A number of analysts have revised their coverage, including BofA Securities’s analysts, who decreased its forecast for the stock in early September from “a Buy” to “a Neutral”. JP Morgan also remained covering VIR and has increased its forecast on March 06, 2023 with a “an Overweight” recommendation from previously “Neutral” rating. Goldman revised its rating on February 21, 2023. It rated VIR as “a Buy” which previously was an “a Neutral”.
Price Performance Review of VIR
On Tuesday, Vir Biotechnology Inc [NASDAQ:VIR] saw its stock fall -0.30% to $9.97. Over the last five days, the stock has lost -0.30%. Vir Biotechnology Inc shares have fallen nearly -0.89% since the year began. Nevertheless, the stocks have fallen -55.67% over the past one year. While a 52-week high of $27.48 was reached on 02/27/24, a 52-week low of $7.72 was recorded on 02/05/24. SMA at 50 days reached $10.17, while 200 days put it at $12.27. A total of 0.6 million shares were traded, compared to the trading of 0.51 million shares in the previous session.
Levels Of Support And Resistance For VIR Stock
The 24-hour chart illustrates a support level at 9.88, which if violated will result in even more drops to 9.80. On the upside, there is a resistance level at 10.13. A further resistance level may holdings at 10.30. The Relative Strength Index (RSI) on the 14-day chart is 41.98, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.56, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 89.95%. Stochastics %K at 11.89% indicates the stock is a buying.
How much short interest is there in Vir Biotechnology Inc?
A steep rise in short interest was recorded in Vir Biotechnology Inc stocks on Feb 29, 2024, dropping by -0.69 million shares to a total of 5.08 million shares. Yahoo Finance data shows the prior-month short interest on Jan 31, 2024 was 5.77 million shares. There was a decline of -13.58%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 6.32% of the overall stock float, the days-to-cover ratio (short ratio) fell to 3.76.
